Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

Literature DB >> 14219455

THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

H KEBERLE.

Abstract

Entities: Chemical

Keywords: DEFEROXAMINE; EXPERIMENTAL LAB STUDY; IRON METABOLISM; RABBITS; RATS

Mesh：

Substances：
Iron
Deferoxamine

Year: 1964 PMID： 14219455 DOI： 10.1111/j.1749-6632.1965.tb54077.x

Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691

Keyword Cloud
Cited

× No keyword cloud information.

95 in total

1. Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.

Authors: He Wu; Tao Wu; Mingchang Li; Jian Wang
Journal: Neurobiol Dis Date: 2011-09-10 Impact factor: 5.996

2. Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect.

Authors: K Chopra; M Singh; N Kaul; K I Andrabi; N K Ganguly
Journal: Mol Cell Biochem Date: 1992-07-06 Impact factor: 3.396

3. ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo.

Authors: Zhi Liu; Jing Qiao; Tamas Nagy; May P Xiong
Journal: J Control Release Date: 2018-05-22 Impact factor: 9.776

4. Nanoparticle and iron chelators as a potential novel Alzheimer therapy.

Authors: Gang Liu; Ping Men; George Perry; Mark A Smith
Journal: Methods Mol Biol Date: 2010

5. Permeabilization of the mitochondrial outer membrane by Bax/truncated Bid (tBid) proteins as sensitized by cardiolipin hydroperoxide translocation: mechanistic implications for the intrinsic pathway of oxidative apoptosis.

Authors: Witold Korytowski; Liana V Basova; Anna Pilat; Robert M Kernstock; Albert W Girotti
Journal: J Biol Chem Date: 2011-06-03 Impact factor: 5.157

THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM.

1. Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.

2. Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect.

3. ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo.

4. Nanoparticle and iron chelators as a potential novel Alzheimer therapy.

5. Permeabilization of the mitochondrial outer membrane by Bax/truncated Bid (tBid) proteins as sensitized by cardiolipin hydroperoxide translocation: mechanistic implications for the intrinsic pathway of oxidative apoptosis.

6. Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.

7. Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats.

8. Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.

9. Nature of anaemia in rheumatoid arthritis. VII. Storage of iron in rheumatoid disease.

10. Management of acute iron poisoning.